Editorial Board About Us

Finasteride

All articles from this key word are listed below.

Volume 2, Number 2 Review Articles

Minimally Invasive Procedures and Medical Management - Their Relative Merits in Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia

Treatment Update

Bob Djavan Michael Marberger

Finasteride Benign prostatic hyperplasia (BPH)Adrenergic -antagonists Diathermy Microwaves

Volume 4, Supplement 5 Supplement

The Potential for Prostate Cancer Chemoprevention

Prostate cancer Chemoprevention Finasteride 5-reductase Androgens

Volume 4, Supplement 5 Supplement

Reducing the Risk of Benign Prostatic Hyperplasia Progression

Claus G Roehrborn

Benign prostatic hyperplasia Finasteride Acute urinary retention Lower

Volume 5, Supplement 5 Supplement

Long-Term Experience With 5-Alpha-Reductase Inhibitors

E Darracott Vaughan

Benign prostatic hyperplasia Finasteride Dihydrotestosterone

Volume 5, Supplement 4 Supplement

Long-Term Experience with 5-Alpha-Reductase Inhibitors

E Darracott Vaughan

Benign prostatic hyperplasia Finasteride Dihydrotestosterone

Volume 6, Supplement 9 Supplement

Comparison of Clinical Trials With Finasteride and Dutasteride

J Curtis Nickel

Benign prostatic hyperplasia Medical therapy Finasteride Dutasteride Dihydrotestosterone 5-reductase

Volume 6, Supplement 9 Supplement

5-Alpha-Reductase: History and Clinical Importance

Leonard S Marks

Benign prostatic hyperplasia Finasteride Dutasteride Dihydrotestosterone 5-reductase Guevedoces

Volume 7, Supplement 4 Review Articles

A Comparison of Varying a-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms

Christopher R Chapple

Tamsulosin Alfuzosin Blockers Benign prostatichyperplasia Finasteride

Volume 7, Number 1 Meeting Reviews

Prostate Cancer Update: 2004

Alan W Partin Stephen J Freedland

Prostate cancer Chemotherapy High-intensity focused ultrasound Docetaxel Finasteride Dutasteride